Primary Site >> Pancreatic Cancer
Gene >> FEZF2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Two-dimensional protein database of human pancreas. PMID: 14760645 Ref: Diagnostic protein discovery using proteolytic peptide targeting and identification. PMID: 15468157 |
Ref: Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. PMID: 16335935 |
Ref: Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. PMID: 16823988 |
Ref: N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. PMID: 17249709 Ref: Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. PMID: 17428079 |
Ref: Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. PMID: 19357035 Ref: Analysis of hydrophilic metabolites in physiological fluids by HPLC-MS using a silica hydride-based stationary phase. PMID: 19569099 |
Ref: Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways. PMID: 20035555 |
Ref: Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets. PMID: 20949480 Ref: Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. PMID: 21691750 Ref: [Comparative proteomics of pancreatic cancer]. PMID: 22007487 |
Ref: SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer. PMID: 22901146 |
Ref: Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer. PMID: 23271396 Ref: [Analysis of pancreatic cancer peripheral blood by comparative proteomics]. PMID: 23578431 Ref: Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein. PMID: 23719603 Ref: Biomarkers screening between preoperative and postoperative patients in pancreatic cancer. PMID: 23991970 |
Ref: Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFbeta1. PMID: 24670043 Ref: [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma]. PMID: 25331466 Ref: Detection of pancreatic cancer biomarkers using mass spectrometry. PMID: 25673969 |
Ref: Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. PMID: 26057990 |
Ref: 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016. PMID: 27090254 |
Ref: Lobophorin K, a New Natural Product with Cytotoxic Activity Produced by Streptomyces sp. M-207 Associated with the Deep-Sea Coral Lophelia pertusa. PMID: 28534807 Ref: Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment. PMID: 28800445 |
Ref: Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer. PMID: 28934848 |